Healthcare provider profile · identity verified

Lynnette Lea Smith, AGNP

Nurse Practitioner · IOWA CITY, IA · NPI 1194357830

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	584	156
Levothyroxine Sodium	Levothyroxine Sodium	476	115
Lisinopril	Lisinopril	338	99
Omeprazole	Omeprazole	318	95
Metformin Hcl	Metformin Hcl	297	79
Gabapentin	Gabapentin	229	70
Simvastatin	Simvastatin	223	64
Hydrochlorothiazide	Hydrochlorothiazide	220	58
Amlodipine Besylate	Amlodipine Besylate	207	58
Metoprolol Succinate	Metoprolol Succinate	197	51
Losartan Potassium	Losartan Potassium	196	57
Allopurinol	Allopurinol	181	54
Pantoprazole Sodium	Pantoprazole Sodium	167	47
Furosemide	Furosemide	163	54
Trazodone Hcl	Trazodone Hcl	155	40
Rosuvastatin Calcium	Rosuvastatin Calcium	154	48
Montelukast Sodium	Montelukast Sodium	135	37
Pravastatin Sodium	Pravastatin Sodium	135	38
Metoprolol Tartrate	Metoprolol Tartrate	131	33
Glipizide	Glipizide	130	31
Potassium Chloride	Potassium Chloride	128	34
Tamsulosin Hcl	Tamsulosin Hcl	128	39
Tramadol Hcl	Tramadol Hcl	118	45
Sertraline Hcl	Sertraline Hcl	106	24
Duloxetine Hcl	Duloxetine Hcl	104	27
Glimepiride	Glimepiride	100	32
Alendronate Sodium	Alendronate Sodium	97	30
Albuterol Sulfate Hfa	Albuterol Sulfate	96	39
Prednisone	Prednisone	96	74
Finasteride	Finasteride	95	24
Jardiance	Empagliflozin	95	22
Fluticasone Propionate	Fluticasone Propionate	93	32
Alprazolam	Alprazolam	82	16
Atenolol	Atenolol	81	21
Cephalexin	Cephalexin	81	60
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	81	22
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	80	25
Eliquis	Apixaban	76	17
Citalopram Hbr	Citalopram Hydrobromide	75	21
Pioglitazone Hcl	Pioglitazone Hcl	74	19
Clopidogrel	Clopidogrel Bisulfate	72	22
Meloxicam	Meloxicam	72	20
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	65	20
Tizanidine Hcl	Tizanidine Hcl	60	20
Metformin Hcl Er	Metformin Hcl	59	21
Ozempic	Semaglutide	59	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	56	22
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	54	52
Benazepril Hcl	Benazepril Hcl	52	15
Januvia	Sitagliptin Phosphate	52	suppressed
Ropinirole Hcl	Ropinirole Hcl	52	18
Ezetimibe	Ezetimibe	50	13
Famotidine	Famotidine	50	14
Buspirone Hcl	Buspirone Hcl	46	14
Triamcinolone Acetonide	Triamcinolone Acetonide	46	26
Trulicity	Dulaglutide	44	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	43	26
Zolpidem Tartrate	Zolpidem Tartrate	43	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	41	11
Fluoxetine Hcl	Fluoxetine Hcl	40	11
Lorazepam	Lorazepam	38	suppressed
Spironolactone	Spironolactone	38	suppressed
Farxiga	Dapagliflozin Propanediol	36	suppressed
Mirtazapine	Mirtazapine	35	12
Xarelto	Rivaroxaban	35	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	34	suppressed
Paroxetine Hcl	Paroxetine Hcl	34	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	33	suppressed
Amoxicillin	Amoxicillin	31	22
Bupropion Xl	Bupropion Hcl	30	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	30	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	29	suppressed
Azithromycin	Azithromycin	28	27
Doxycycline Monohydrate	Doxycycline Monohydrate	28	28
Glipizide Er	Glipizide	28	suppressed
Lovastatin	Lovastatin	28	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	28	13
Warfarin Sodium	Warfarin Sodium	28	suppressed
Diclofenac Sodium	Diclofenac Sodium	26	suppressed
Oxycodone Hcl	Oxycodone Hcl	26	suppressed
Carvedilol	Carvedilol	25	suppressed
Mounjaro	Tirzepatide	25	suppressed
Pregabalin	Pregabalin	24	suppressed
Baclofen	Baclofen	22	suppressed
Donepezil Hcl	Donepezil Hcl	22	suppressed
Lansoprazole	Lansoprazole	22	suppressed
Nifedipine Er	Nifedipine	22	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	21	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	21	suppressed
Torsemide	Torsemide	21	suppressed
Valacyclovir	Valacyclovir Hcl	21	suppressed
Ventolin Hfa	Albuterol Sulfate	21	suppressed
Dexlansoprazole Dr	Dexlansoprazole	20	suppressed
Nystatin	Nystatin	20	12
Terazosin Hcl	Terazosin Hcl	20	suppressed
Bupropion Hcl	Bupropion Hcl	19	suppressed
Diazepam	Diazepam	19	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	19	suppressed
Gemfibrozil	Gemfibrozil	19	suppressed
Levetiracetam	Levetiracetam	19	suppressed
Synthroid	Levothyroxine Sodium	19	suppressed
Chlorthalidone	Chlorthalidone	18	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	18	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	17	17
Raloxifene Hcl	Raloxifene Hcl	17	suppressed
Symbicort	Budesonide/Formoterol Fumarate	17	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	15	suppressed
Irbesartan	Irbesartan	15	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	15	suppressed
Ramipril	Ramipril	15	suppressed
Rybelsus	Semaglutide	15	suppressed
Topiramate	Topiramate	15	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	15	suppressed
Fenofibrate	Fenofibrate	14	suppressed
Hydralazine Hcl	Hydralazine Hcl	14	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	14	suppressed
Indapamide	Indapamide	14	suppressed
Novolog Flexpen	Insulin Aspart	14	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	14	suppressed
Primidone	Primidone	14	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Celecoxib	Celecoxib	13	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	13	suppressed
Tresiba Flextouch U-100	Insulin Degludec	13	suppressed
Azelastine Hcl	Azelastine Hcl	12	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	12	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	12	suppressed
Lacosamide	Lacosamide	12	suppressed
Propranolol Hcl	Propranolol Hcl	12	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	12	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	11	suppressed
Neupro	Rotigotine	11	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error